Can we predict the IVF/ICSI live birth rate?
- PMID: 31361435
- PMCID: PMC6798599
- DOI: 10.5935/1518-0557.20190043
Can we predict the IVF/ICSI live birth rate?
Abstract
Objectives: To find a pretreatment predictor for achieving a live birth. Assisted reproduction technology with IVF/ICSI is the ultimate chance for some couples to conceive a child. The expectations are high and it is important to give them a realistic perspective about the chances of achieving a live birth.
Methods: A retrospective cohort study of all IVF/ICSI cycles performed in our center between 2012 and 2016. We considered only those cycles with a live birth delivery after 24 weeks, or cycles with no surplus embryos left. The following data was evaluated: AMH; AFC; age; BMI; previous diagnosis; type of treatment; number of previous deliveries; ethnicity, smoking status. Univariate and multivariate analysis were used to examine the association of live birth with baseline patient characteristics. We determined the odds-ratio for all the statistically significant variables (p<0.05), in a multivariate model. The results are presented according to the predictors founded.
Results: 739 cycles were evaluated: 9.1% were canceled; 10.2% did not have oocytes; 15.6% did not have D2 embryos; 31.4% achieved a live birth. The univariate analysis revealed statistically significant differences regarding AMH, AFC and women's age between couples with and without a live birth (p<0.001), and the cause of infertility. We found no association with live births in other variables. These variables were categorized and used in a multivariate analysis.
Conclusion: Age, AMH, AFC and cause, when sub-classified, are independently associated with the results of an IVF/ICSI treatment. These results enable couples to face real expectations in their particular scenario.
Keywords: age; antimullerian hormone; antral follicle count; in vitro fertilization; live-birth rate; predictor.
Similar articles
-
ICSI does not increase the cumulative live birth rate in non-male factor infertility.Hum Reprod. 2018 Jul 1;33(7):1322-1330. doi: 10.1093/humrep/dey118. Hum Reprod. 2018. PMID: 29897449
-
Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates.Hum Reprod. 2016 Dec;31(12):2750-2755. doi: 10.1093/humrep/dew247. Epub 2016 Oct 13. Hum Reprod. 2016. PMID: 27738114 Free PMC article.
-
The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.Hum Reprod. 2017 Jan;32(1):119-124. doi: 10.1093/humrep/dew298. Epub 2016 Nov 16. Hum Reprod. 2017. PMID: 27852688
-
Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:151-155. doi: 10.1016/j.ejogrb.2017.12.047. Epub 2017 Dec 29. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29306180
-
Predictors of success after in vitro fertilization.Fertil Steril. 2024 May;121(5):742-751. doi: 10.1016/j.fertnstert.2024.03.003. Epub 2024 Mar 16. Fertil Steril. 2024. PMID: 38492930 Review.
Cited by
-
Follicle Stimulating Hormone (FSH) as a Predictor of Decreased Oocyte Yield in Patients with Normal Anti-Müllerian Hormone (AMH) and Antral Follicle Count (AFC).J Reprod Infertil. 2023 Jul-Sep;24(3):181-187. doi: 10.18502/jri.v24i3.13274. J Reprod Infertil. 2023. PMID: 37663421 Free PMC article.
-
In-Vitro Fertilization Outcome Predictors in Women With High Baseline Follicle-Stimulating Hormone Levels: Analysis of Over 1000 Cycles From A Tertiary Center.JBRA Assist Reprod. 2021 Apr 27;25(2):235-241. doi: 10.5935/1518-0557.20200088. JBRA Assist Reprod. 2021. PMID: 33710840 Free PMC article.
-
Anti-müllerian hormone as a predictor for live birth among women undergoing IVF/ICSI in different age groups: an update of systematic review and meta-analysis.Arch Gynecol Obstet. 2023 Jul;308(1):43-61. doi: 10.1007/s00404-022-06683-1. Epub 2022 Jul 30. Arch Gynecol Obstet. 2023. PMID: 35907969
-
Non-coding RNAs from seminal plasma extracellular vesicles and success of live birth among couples undergoing fertility treatment.Front Cell Dev Biol. 2023 Jun 22;11:1174211. doi: 10.3389/fcell.2023.1174211. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37427387 Free PMC article.
-
Clinical data-based modeling of IVF live birth outcome and its application.Reprod Biol Endocrinol. 2024 Jul 8;22(1):76. doi: 10.1186/s12958-024-01253-3. Reprod Biol Endocrinol. 2024. PMID: 38978032 Free PMC article.
References
-
- Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, Eijkemans MJC, Mol BW, Broekmans FJ, IMPORT study group Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36. doi: 10.1093/humupd/dms041. - DOI - PubMed
-
- CNPMA - Conselho Nacional de Procriação Medicamente Assistida . Relatório - Atividade desenvolvida pelos centros de PMA em 2015. Lisboa: CNPMA; 2017. https://www.spmr.pt/files/RELATORIO_ATIVIDADE_PMA2015.pdf
-
- Hamdine O, Eijkemans MJC, Lentjes EGW, Torrance HL, Macklon NS, Fauser BCJM, Broekmans FJ. Antimullerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization. Fertil Steril. (e2) 2015;104:891–898. doi: 10.1016/j.fertnstert.2015.06.030. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical